Pantuo Lazuo Na (泮托拉唑钠)泮托拉唑钠

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

泮托拉唑是一种在国家药监局注册认定的药品。该药品含有泮托拉唑-449cb32b等成分。

该药品关联的活性成分包括:泮托拉唑pantoprazole。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂。

您可以探索含有相同成分的其他药品:泮托拉唑-449cb32b成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

pantoprazole is a medicine registered with the national drug regulatory authority. It contains pantoprazole as active ingredient(s).

Active ingredients associated with this product: pantoprazolepantoprazole.

Manufacturers recorded for this product: 江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂.

Explore other medicines containing the same ingredient: pantoprazole products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 泮托拉唑钠Recorded Chinese name: 泮托拉唑钠
  • 规格Specification: - -

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 江苏吴中医药集团有限公司苏州制药厂Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20074023

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20074023

Manufacturer

Chinese legal name: 江苏吴中医药集团有限公司苏州制药厂 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20074023

生产企业

江苏吴中医药集团有限公司苏州制药厂(国产)

适应症

治疗轻度反流性食管炎及其伴随症状(如烧心、反酸、吞咽疼痛),用于反流性食管炎的长期维持治疗,防止复发。

用法用量

遵医嘱用。

不良反应

临床应用偶有头痛、头晕、失眠、嗜睡、恶心、腹痛、腹泻和便秘、腹胀、皮疹、肌肉疼痛等症状。

禁忌

1.哺乳期妇女及妊娠三个月内妇女禁用。 |2.对本品过敏者禁用。

注意事项

1.本品为肠溶制剂,服用时请勿咀嚼。 |2.当怀疑胃溃疡时,应首先排除癌症的可能性,因为本品治疗可减轻其症状,从而延误诊断。 |3.肝肾功能不全者慎用,严重肝病时本品清除延缓,应减少用量。 |4.为防止抑酸过度,除卓-艾综合征外,建议用于消化性溃疡等病时,不宜大剂量长期应用。

贮藏

遮光,密封保存。

规格

- -

证据Evidence

  • 批准文号: 国药准字H20074023
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.